Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Belinostat as Consolidation Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

NCT02737046 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT02737046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02737046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Belinostat as Consolidation Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Lead sponsor
University of Miami
Phase
Phase 2
Overall status
Completed
Start date
December 12, 2016
Completion date
December 31, 2025
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult t-cell leukemia-lymphoma, atll